Related Experiment Video
Updated: May 13, 2026
12:09
A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
SNAP-tag based agents for preclinical in vitro imaging in malignant diseases
Manal Amoury1, Tobias Blume, Hannes Brehm
1Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Forckenbeckstr. 6, 52074 Aachen, Germany.
Current Pharmaceutical Design
|February 26, 2013
Summary
Researchers evaluated antibody fragments (scFv) for cancer therapy by tracking their internalization into tumor cells. They found that bivalent constructs showed faster internalization, aiding early assessment of therapeutic potential.
Area of Science:
- Biotechnology
- Cancer Research
- Immunotherapy
Background:
- Current cancer treatments often fail to eliminate all malignant cells, necessitating novel strategies.
- Antibody-based therapeutics, like immunotoxins, show promise but require efficient internalization for efficacy.
- Understanding the internalization behavior of antibody fragments is crucial for developing effective cancer therapies.
Purpose of the Study:
- To determine the internalization behavior of four different single-chain fragments variable (scFv) targeting tumor cells.
- To assess the potential of scFvs fused to SNAP-tag for imaging and evaluating internalization kinetics.
- To investigate the effect of bivalency on scFv internalization rates.
Main Methods:
- Recombinant fusion of scFvs to SNAP-tag for covalent labeling with fluorescent dyes.
- Utilizing SNAP-surface® Alexa Fluor® conjugates for labeling.
- Monitoring binding and internalization using flow cytometry and confocal microscopy.
Main Results:
- Distinct internalization rates (slow and rapid) were observed depending on the target antigen.
- Bivalent scFv constructs demonstrated an increased internalization rate compared to monovalent ones.
- The SNAP-tag system proved versatile for imaging intracellular and extracellular compartments.
Conclusions:
- The study provides a method for rapid, early-stage evaluation of antibody fragment internalization characteristics.
- This approach aids in selecting promising antibody candidates for further therapeutic development.
- Understanding internalization kinetics is key to optimizing antibody-based cancer immunotherapies.
